AR055642A1 - USE OF MASLINIC ACID AS AN ANTIPARASITARY AGAINST PROTOZOOS OF PHYLLUM APICOMPLEX - Google Patents

USE OF MASLINIC ACID AS AN ANTIPARASITARY AGAINST PROTOZOOS OF PHYLLUM APICOMPLEX

Info

Publication number
AR055642A1
AR055642A1 ARP060104104A ARP060104104A AR055642A1 AR 055642 A1 AR055642 A1 AR 055642A1 AR P060104104 A ARP060104104 A AR P060104104A AR P060104104 A ARP060104104 A AR P060104104A AR 055642 A1 AR055642 A1 AR 055642A1
Authority
AR
Argentina
Prior art keywords
phyllum
maslinic acid
protozoos
apicomplex
antiparasitary
Prior art date
Application number
ARP060104104A
Other languages
Spanish (es)
Inventor
Granados Lopez De Hierr Garcia
Albornoz Osuna Carrillo Ant De
Sanchez Andres Parra
Pablos Torro Luis Miguel De
Original Assignee
Univ Granada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Granada filed Critical Univ Granada
Publication of AR055642A1 publication Critical patent/AR055642A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Utilizacion de ácido maslínico como antiparasitario frente a Protozoos del Phyllum Apicomplexa. El ácido 2-alfa,3-betadihidroxi-28-carboxiolean-12-eno (ácido maslínico), sus sales y derivados se utilizan como inhibidores de serin-proteasas para la obtencion de preparados destinados al tratamiento y prevencion de parasitosis causadas en humanos y animales por las especies del Phyllum Apicomplexa: Eimeria, Toxoplasma, Neospora, Cyclospora, Isospora, Besnoisia, Babesia y Plasmodium.Use of maslinic acid as an antiparasitic against Protozoa of Phyllum Apicomplexa. The 2-alpha, 3-betadihydroxy-28-carboxylean-12-ene (maslinic acid) acid, its salts and derivatives are used as serine protease inhibitors to obtain preparations for the treatment and prevention of parasitosis caused in humans and animals by the species of Phyllum Apicomplexa: Eimeria, Toxoplasma, Neospora, Cyclospora, Isospora, Besnoisia, Babesia and Plasmodium.

ARP060104104A 2005-09-20 2006-09-19 USE OF MASLINIC ACID AS AN ANTIPARASITARY AGAINST PROTOZOOS OF PHYLLUM APICOMPLEX AR055642A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200502349A ES2282027B1 (en) 2005-09-20 2005-09-20 USE OF MASLINIC ACID AS ANTIPARASITARY AGAINST PROTOZOOS OF THE PHYLLUM APICOMPLEXA.

Publications (1)

Publication Number Publication Date
AR055642A1 true AR055642A1 (en) 2007-08-29

Family

ID=37889164

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104104A AR055642A1 (en) 2005-09-20 2006-09-19 USE OF MASLINIC ACID AS AN ANTIPARASITARY AGAINST PROTOZOOS OF PHYLLUM APICOMPLEX

Country Status (3)

Country Link
AR (1) AR055642A1 (en)
ES (1) ES2282027B1 (en)
WO (1) WO2007034009A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101619088B (en) * 2009-08-04 2012-07-04 上海朴颐化学科技有限公司 Maslinic acid derivative as well as preparation and application thereof
ES2392522A1 (en) * 2011-05-28 2012-12-11 Universidad De La Laguna Composition for the maintenance of contact lenses that results effective against acanthamoeba ssp. (Machine-translation by Google Translate, not legally binding)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888518A (en) * 1995-10-06 1999-03-30 Beretich, Sr.; Guy R. Method for preventing and treating coccidiosis
ES2131467B1 (en) * 1997-05-12 2000-04-01 Univ Granada USE OF MASLINIC ACID AS A SERIN-PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENE CRYPTOSPORIDIUM.
EP1578429A4 (en) * 2002-05-22 2006-12-06 Smithkline Beecham Corp Protease inhibitors

Also Published As

Publication number Publication date
ES2282027B1 (en) 2008-10-01
WO2007034009A2 (en) 2007-03-29
ES2282027A1 (en) 2007-10-01
WO2007034009A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
CR9146A (en) POTASSIC SALT OF AN HIV INTEGRAS INHIBITOR
EA201300987A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING METHORMENE AND DPP-4 INHIBITOR OR SGLT-2 INHIBITOR
SV2009003299A (en) USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE
PE20170306A1 (en) NEW MODIFIED RELEASE DOSAGE FORMS OF A XANTHINE OXIDOR REDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS
AR059964A1 (en) METHODS TO REDUCE PROTEIN AGLOMERATION
MX352823B (en) Protein formulations containing amino acids.
DOP2012000105A (en) SPIROPIPERIDINE COMPOUNDS AND PHARMACEUTICAL USE OF THE SAME TO TREAT DIABETES
UY30587A1 (en) BENZOXAZOLES AND OXAZOLOPIRIDINES THAT ARE USEFUL AS INHIBITORS OF THE S JANUS CINASES
CR20150196A (en) ILL-17A NOVEDOUS UNION MOLECULES AND MEDICAL USES OF THE SAME
AR083126A1 (en) VACCINE COMPOSITION FOR CONTROL OF INFESTATIONS BY ECTOPARASITES
MX2010007670A (en) Use of an acetylsalicylic acid salt for the treatment of viral infections.
BR112013004956A2 (en) "Tobacco axillary button growth inhibitor and method for inhibiting tobacco axillary button growth".
ECSP077240A (en) IMPROVED APROTININ VARIANTS
CR20180497A (en) CONJUGATED C1 ESTERASE INHIBITOR AND ITS USES
AR087094A1 (en) FORMULATIONS THAT STABILIZE PROTEINS
CL2011001258A1 (en) Citric acid addition salts of (r) -5 - ((e) -2-pyrrolidin-3-yl vinyl) pyrimidine; polymorphic monoitrate forms; pharmaceutical composition that includes them; and its use in the prevention or treatment of pain, inflammation or a disorder of the central nervous system.
CO2022010224A2 (en) Engineered acid alpha-glucosidase variants
AR055642A1 (en) USE OF MASLINIC ACID AS AN ANTIPARASITARY AGAINST PROTOZOOS OF PHYLLUM APICOMPLEX
EA201171431A1 (en) APPLICATION OF THE COMBINATION OF D-ASPARAGINOUS AND L-ASPARAGIC ACIDS OR THEIR SALTS FOR THE TREATMENT OF MALE INFERTILITY
NZ741573A (en) Anti-cd43 antibody and use thereof for cancer treatment
AR090244A1 (en) FORMULATION OF ANTI-SELECTINE ANTIBODY P
CO2017012397A2 (en) Fragment of human anti-ngf fab antibody
EA201792122A1 (en) CRYSTALLINE CONNECTION AS A STERICARBAS-SENSITIVE AMINOXIDASE ENZYME INHIBITOR (SSAO)
BR112013025236A2 (en) thieno [2,3-d) pyrimidine derivatives and their use in the treatment of arrhythmia
EA201171142A1 (en) TABLETS OF RETIGABIN PREFERREDLY WITH MODIFIED FREEDOM

Legal Events

Date Code Title Description
FB Suspension of granting procedure